We have previously shown that the treatment of colon cancer cells with CPT may trigger Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling, which is inhibited by the indole compound, BEI-9 [17,18]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.